US FDA Approve Zydus Lifesciences’ Febuxostat Tablets to Treat Uric Acid
India’s pharmaceutical giant Zydus Lifesciences claims to have received final approval from the Food and Drug Administration (FDA) of the United States to sell 40 mg and 80 mg of Febuxostat tablets. According to Zydus Lifesciences, Febuxostat tablets are meant to lower hyperuricemia, or high blood uric acid, in people with gout who have been […]
Continue Reading